Q3 Medical USA, LLC

Q3 Medical USA, LLC is a subsidiary of Q3 Medical Group, an Irish medical device holding company specializing in the development, manufacturing, and global distribution of innovative minimally invasive and biodegradable medical devices. The company focuses on cardiology, peripheral vascular, and non-vascular applications, with particular expertise in biodegradable implants, micro-invasive technologies, and drug delivery platforms. Q3 Medical's flagship product, ARCHIMEDES, is the first fully biodegradable biliary and pancreatic stent, designed to eliminate the need for removal procedures while reducing complications and healthcare costs. Operating through subsidiaries in Germany, China, and the USA, the company employs a clinician-led, multidisciplinary approach to develop patient-centric solutions that streamline treatment pathways, reduce hospital stays, and lower overall healthcare expenses. The company is committed to advancing sustainable healthcare through innovative technologies that balance superior patient outcomes with economic and environmental benefits.